Pineapple Express Cannabis (PNXP) Receivables (2024)

Pineapple Express Cannabis' (PNXP) quarterly Receivables came in at $14204.0 in Q4 2024, up 43.88% quarter-over-quarter from $9872.0 in Q3 2024.

Pineapple Express Cannabis (PNXP) Receivables (2024) Analysis & Trends

Pineapple Express Cannabis has disclosed Receivables across 1 years of filings, most recently posting $14204.0 for Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Receivables (Qtr)
1	Teva Pharmaceutical Industries	38.34 Bn	34.60 Bn	1.97 Bn	3.39 Bn
2	Zoetis	33.27 Bn	31.33 Bn	1.62 Bn	1.51 Bn
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn	312.00 Mn
4	Aurora Cannabis	17.11 Bn	17.03 Bn	33.43 Mn	31.29 Mn
5	Neurocrine Biosciences	16.37 Bn	15.05 Bn	800.70 Mn	768.10 Mn
6	Elanco Animal Health	11.78 Bn	11.35 Bn	785.00 Mn	1.15 Bn
7	Alkermes	7.05 Bn	6.54 Bn	-116.06 Mn	407.63 Mn
8	Lantheus Holdings	6.49 Bn	5.99 Bn	230.92 Mn	355.67 Mn
9	Hims & Hers Health	6.19 Bn	5.44 Bn	396.79 Mn	149.62 Mn
10	Pineapple Express Cannabis	-	-	-	-

Download Data